Published February 28, 2023 | Version v1
Journal article Open

Anemic Syndrome and Molecular Mechanisms and Regulation of Iron Absorption in Gastroenterological Diseases

Creators

  • 1. Institute of Haematology and Transfusiology of the NAMS of Ukraine, Ukraine
  • 2. P. L. Shupyk National Healthcare University of Ukraine, Ukraine

Description

Anemic syndrome is the most often extraintestinal complication in patients with diseases of the digestive tract (DT), which can significantly impair the quality of life. In the literature review, we tried to combine and systematize the accumulated information on the problem of anemic syndrome in DT diseases.

Iron-deficiency anemia, chronic disease anemia, B12-deficiency and folio-deficiency anemia are determined depending on the combination of pathogenetic mechanisms. Other variants of anemia are rare. It is necessary to carry out a complex laboratory examination to establish the leading factor in the development of anemia and determine the adequate therapy. Anemia of inflammatory disease is one of the frequent complications in patients with DT diseases. For the correction of such anemia in clinical practice, iron preparations are used parenterally. However, such therapy can lead to an excess of iron and worsen the course of the underlying disease.

The understanding the anemia pathogenesis is important for prescribing therapy and minimizing the risk of complications. Parenteral forms of iron and vitamin preparations should be prioritized for this category of patients due to their higher bioavailability, low safety profile and minimal negative impact on DT. Erythropoietin preparations and inhibitors of proinflammatory cytokines are mainly used to correct anemia of chronic inflammation. Pro-inflammatory cytokines are effective for patients with anemic syndrome and severe inflammatory bowel processes. According to the literature data, various clinical studies aimed at the introduction of new drugs that correct anemia are being conducted.

The review presents modern methods of diagnosis and treatment of anemia in order to better understand this disease. A further study of patients with gastroenterological diseases, the course of which is complicated by anemia, is necessary to form a final conclusion about the disease, the effectiveness and feasibility of prescribing parenteral forms of iron preparations.

Files

Anemic_Syndrome_and_Molecular_Mechanisms_and_Regulation_of_Iron_Absorption_in_Gastroenterological_Diseases.pdf

Files (1.5 MB)

Additional details

References

  • Beaumont C. Mécanismes moléculaires de l'homéostasie du fer [Molecular mechanisms of iron homeostasis]. Med Sci (Paris). 2004;20(1):68–72. French. doi: 10.1051/medsci/200420168
  • Beaumont C, Canonne-Hergaux F. Erythrophagocytose et recyclage du fer héminique dans les conditions normales et pathologiques; régulation par l'hepcidine [Erythrophagocytosis and recycling of heme iron in normal and pathological conditions; regulation by hepcidin]. Transfus Clin Biol. 2005;12(2):123–30. doi: 10.1016/j.tracli.2005.04.017
  • Bergamaschi G, Di Sabatino A, Corazza GR. Pathogenesis, diagnosis and treatment of anaemia in immune-mediated gastrointestinal disorders. Br J Haematol. 2018;182(3):319–29. doi: 10.1111/bjh.15254.
  • Bergamaschi G, Di Sabatino A, Pasini A, Ubezio C, Costanzo F, Grataroli D, et al. Intestinal expression of genes implicated in iron absorption and their regulation by hepcidin. Clin Nutr. 2017;36(5):1427–1433. doi: 10.1016/j.clnu.2016.09.021
  • Cavallaro F, Duca L, Pisani LF, Rigolini R, Spina L, Tontini GE, et al. Anti-TNF-Mediated Modulation of Prohepcidin Improves Iron Availability in Inflammatory Bowel Disease, in an IL-6-Mediated Fashion. Can J Gastroenterol Hepatol. 2017;2017:6843976. doi: 10.1155/2017/6843976.
  • De Domenico I, Ward DM, Nemeth E, Vaughn MB, Musci G, Ganz T, et al. The molecular basis of ferroportin-linked hemochromatosis. Proc Natl Acad Sci USA. 2005;102(25):8955–60. doi: 10.1073/pnas.0503804102
  • Delaby C, Pilard N, Gonçalves AS, Beaumont C, Canonne-Hergaux F. Presence of the iron exporter ferroportin at the plasma membrane of macrophages is enhanced by iron loading and down-regulated by hepcidin. Blood. 2005;106(12):3979–84. doi: 10.1182/blood-2005-06-2398
  • Desjardins M. ER-mediated phagocytosis: a new membrane for new functions. Nat Rev Immunol. 2003;3(4):280–91. doi: 10.1038/nri1053.
  • Détivaud L, Nemeth E, Boudjema K, Turlin B, Troadec MB, Leroyer P, et al. Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function. Blood. 2005;106(2):746–8. doi: 10.1182/blood-2004-12-4855.
  • Devalia V, Hamilton MS, Molloy AM; British Committee for Standards in Haematology. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014;166(4):496–513. doi: 10.1111/bjh.12959.
  • Dignass AU, Gasche C, Bettenworth D, Birgegård G, Danese S, Gisbert JP, Gomollon F, et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis. 2015;9(3):211–22. doi: 10.1093/eccojcc/jju009
  • Donovan A, Lima CA, Pinkus JL, Pinkus GS, Zon LI, Robine S, Andrews NC. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 2005;1(3):191–200. doi: 10.1016/j.cmet.2005.01.003
  • Drakesmith H, Schimanski LM, Ormerod E, Merryweather-Clarke AT, Viprakasit V, Edwards JP, Sweetland E, Bastin JM, Cowley D, Chinthammitr Y, Robson KJ, Townsend AR. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood. 2005;106(3):1092–7. doi: 10.1182/blood-2005-02-0561
  • Evstatiev R, Marteau P, Iqbal T, Khalif IL, Stein J, Bokemeyer B, Chopey IV, Gutzwiller FS, Riopel L, Gasche C; FERGI Study Group. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology. 2011;141(3):846–853.e1-2. doi: 10.1053/j.gastro.2011.06.005.
  • Frazer DM, Anderson GJ. Iron imports. I. Intestinal iron absorption and its regulation. Am J Physiol Gastrointest Liver Physiol. 2005;289:G631–5.
  • Frazer DM, Anderson GJ. The orchestration of body iron intake: how and where do enterocytes receive their cues? Blood Cells Mol Dis. 2003;30(3):288–97. doi: 10.1016/s1079-9796(03)00039-1.
  • Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 2003;102(3):783–8. doi: 10.1182/blood-2003-03-0672.
  • Gasche C, Lomer MC, Cavill I, Weiss G. Iron, anemia, and inflammatory bowel disease. Gut. 2004;53(8):1190–7. doi: 10.1136/gut.2003.035758.
  • Green R. Vitamin B12 deficiency from the perspective of a practicing hematologist. Blood. 2017;129(19):2603–11. doi: 10.1182/blood-2016-10-569186
  • Greer JP, Arber DA, Glader B, editors. Wintrobe's clinical hematology 13th ed. Philadelphia: Lippincott Williams & Wilkins; 2014. 2278 p.
  • Gunshin H, Starr CN, Direnzo C, Fleming MD, Jin J, Greer EL, et al. Cybrd1 (duodenal cytochrome b) is not necessary for dietary iron absorption in mice. Blood. 2005;106(8):2879–83. doi: 10.1182/blood-2005-02-0716
  • Hentze MW, Muckenthaler MU, Andrews NC. Balancing acts: molecular control of mammalian iron metabolism. Cell. 2004;117(3):285–97. doi: 10.1016/s0092-8674(04)00343-5
  • Hetet G, Devaux I, Soufir N, Grandchamp B, Beaumont C. Molecular analyses of patients with hyperferritinemia and normal serum iron values reveal both L ferritin IRE and 3 new ferroportin (slc11A3) mutations. Blood. 2003;102(5):1904–10. doi: 10.1182/blood-2003-02-0439
  • Hubert N, Hentze MW. Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function. Proc Natl Acad Sci USA. 2002;99(19):12345–50. doi: 10.1073/pnas.192423399
  • Iqbal T, Stein J, Sharma N, Kulnigg-Dabsch S, Vel S, Gasche C. Clinical significance of C-reactive protein levels in predicting responsiveness to iron therapy in patients with inflammatory bowel disease and iron deficiency anemia. Dig Dis Sci. 2015;60(5):1375–81. doi: 10.1007/s10620-014-3460-4
  • Katsanos KH, Tatsioni A, Natsi D, Sigounas D, Christodoulou DK, Tsianos EV. Recombinant human erythropoietin in patients with inflammatory bowel disease and refractory anemia: a 15-year single center experience. J Crohns Colitis. 2012;6(1):56–61. doi: 10.1016/j.crohns.2011.07.004
  • Kodadek LM, Jones C. Stress gastritis and stress ulcers: Prevention and treatment. In Surgical Critical Care Therapy. A Clinically Oriented Practical Approach. Berlin: Springer International Publishing; 2018, p. 231–9. doi: 10.1007/978-3-319-71712-8_21
  • Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 2000;480(2-3):147–50. doi: 10.1016/s0014-5793(00)01920-7
  • Lee P, Peng H, Gelbart T, Wang L, Beutler E. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci USA. 2005;102(6):1906–10. doi: 10.1073/pnas.0409808102
  • Lin L, Goldberg YP, Ganz T. Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin. Blood. 2005;106(8):2884–9. doi: 10.1182/blood-2005-05-1845
  • Liu XB, Nguyen NB, Marquess KD, Yang F, Haile DJ. Regulation of hepcidin and ferroportin expression by lipopolysaccharide in splenic macrophages. Blood Cells Mol Dis. 2005;35(1):47–56. doi: 10.1016/j.bcmd.2005.04.006
  • Matsunaga E, Chédotal A. Repulsive guidance molecule/neogenin: a novel ligand-receptor system playing multiple roles in neural development. Dev Growth Differ. 2004;46(6):481–6. doi: 10.1111/j.1440-169x.2004.00768.x
  • McKie AT, Barlow DJ. The SLC40 basolateral iron transporter family (IREG1/ferroportin/MTP1). Pflugers Arch. 2004;447(5):801–6. doi: 10.1007/s00424-003-1102-3
  • Murawska N, Fabisiak A, Fichna J. Anemia of Chronic Disease and Iron Deficiency Anemia in Inflammatory Bowel Diseases: Pathophysiology, Diagnosis, and Treatment. Inflamm Bowel Dis. 2016;22(5):1198–208. doi: 10.1097/MIB.0000000000000648
  • Murray-Koble LE, Beard J, Coates PM. Iron. Encyclopedia of dietary Supplement, 2nd ed. London & New York: Inform a health care; 2010, p. 432–8. doi: 10/1016/S0140-6736(82)92204-8
  • Mücke V, Mücke MM, Raine T, Bettenworth D. Diagnosis and treatment of anemia in patients with inflammatory bowel disease. Ann Gastroenterol. 2017;30(1):15–22. doi: 10.20524/aog.2016.0083
  • Nielsen OH, Ainsworth M, Coskun M, Weiss G. Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease: A Systematic Review. Medicine (Baltimore). 2015;94(23):e963. doi: 10.1097/MD.0000000000000963
  • Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113(9):1271–6. doi: 10.1172/JCI20945
  • Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306(5704):2090–3. doi: 10.1126/science.1104742
  • Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003;101(7):2461–3. doi: 10.1182/blood-2002-10-3235
  • Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA. 2001;98(15):8780–5. doi: 10.1073/pnas.151179498
  • Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA. 2002;99(7):4596–601. doi: 10.1073/pnas.072632499
  • Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002;110(7):1037–44. doi: 10.1172/JCI15686
  • Ohgami RS, Campagna DR, Greer EL, Antiochos B, McDonald A, Chen J, et al. Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells. Nat Genet. 2005;37(11):1264–9. doi: 10.1038/ng1658
  • Okam MM, Koch TA, Tran MH. Iron Supplementation, Response in Iron-Deficiency Anemia: Analysis of Five Trials. Am J Med. 2017;130(8):991.e1–991.e8. doi: 10.1016/j.amjmed.2017.03.045
  • Papanikolaou G, Tzilianos M, Christakis JI, Bogdanos D, Tsimirika K, Mac-Farlane J, et al. Hepcidin in iron overload disorders. Blood. 2005;105(10):4103–5. doi: 10.1182/blood-2004-12-4844
  • Pennelli G, Grillo F, Galuppini F, Ingravallo G, Pilozzi E, Rugge M, et al. Gastritis: update on etiological features and histological practical approach. Pathologica. 2020;112(3):153–65. doi: 10.32074/1591-951X-163
  • Pereira DI, Couto Irving SS, Lomer MC, Powell JJ. A rapid, simple questionnaire to assess gastrointestinal symptoms after oral ferrous sulphate supplementation. BMC Gastroenterol. 2014;14:103. doi: 10.1186/1471-230X-14-103
  • Pietrangelo A. The ferroportin disease. Blood Cells Mol Dis. 2004;32(1):131–8. doi: 10.1016/j.bcmd.2003.08.003
  • Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2001;276(11):7811–9. doi: 10.1074/jbc.M008923200
  • Popovich MU. Structure, functions and biological roles. On the problems of science and practice, tasks and ways to solve them: In: Material of the VI International Scientific and Practical Conference; 2020 Oct 26-30; Milan. Milan; 2020, p. 240–243. doi: 10.46299/ISG.2020.II.VI
  • Popovych M. Iron deficiency anemia: Assesment of iron status in the human body by serum ferritin level, taking into account WHO Recommendations. Hematol. Transfusiol. Eastern Europe. 2020;6(4):479–88
  • Priwitzerova M, Pospisilova D, Prchal JT, Indrak K, Hlobilkova A, Mihal V, et al. Severe hypochromic microcytic anemia caused by a congenital defect of the iron transport pathway in erythroid cells. Blood. 2004;103(10):3991–2. doi: 10.1182/blood-2004-01-0225
  • Ramalingam TS, West AP Jr, Lebron JA, Nangiana JS, Hogan TH, Enns CA, et al. Binding to the transferrin receptor is required for endocytosis of HFE and regulation of iron homeostasis. Nat Cell Biol. 2000;2(12):953–7. doi: 10.1038/35046611
  • Rivera S, Nemeth E, Gabayan V, Lopez MA, Farshidi D, Ganz T. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood. 2005;106(6):2196–9. doi: 10.1182/blood-2005-04-1766
  • Shayeghi M, Latunde-Dada GO, Oakhill JS, Laftah AH, Takeuchi K, Halliday N, et al. Identification of an intestinal heme transporter. Cell. 2005;122(5):789–801. doi: 10.1016/j.cell.2005.06.025
  • Stein J, Connor S, Virgin G, Ong DE, Pereyra L. Anemia and iron deficiency in gastrointestinal and liver conditions. World J Gastroenterol. 2016;22(35):7908–25. doi: 10.3748/wjg.v22.i35.7908
  • Tolkien Z, Stecher L, Mander AP, Pereira DI, Powell JJ. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One. 2015;10(2):e0117383. doi: 10.1371/journal.pone.0117383
  • Tsiolakidou G, Koutroubakis IE. Stimulating erythropoiesis in inflammatory bowel disease associated anemia. World J Gastroenterol. 2007;13(36):4798–806. doi: 10.3748/wjg.v13.i36.4798
  • Tulewicz-Marti E, Moniuszko A, Rydzewska G. Management of anemia in inflammatory bowel disease: a challenge in everyday clinical practice. Prz Gastroenterol. 2017;12(4):239–43. doi: 10.5114/pg.2017.72096
  • Ministry of Health Protection of Ukraine.Unification of the clinical protocol of the primary and secondary (specialized) medical assistance «Zalizodeficitna Anemia» [Internet]. 2015. Order No. 709. 2015 leaf fall 02. Available from: https://zakon.rada.gov.ua/rada/show/v0709282-15#Text
  • Vidiborets SV. Metabolism of saliva and salivation: Monograph. Boston: Primedia eLaunch; 2022. 264 p. doi: 10.46299/979-8-88831-932-1
  • Vidiborets S, Borisenko D. Hepcidin, transferrin, feritin: physiological role as the central regulators of the exchange of air in the body. Science Review (Poland). 2019;10(27):8–15. doi: 10.31435/rsglobal_sr/30122019/6862
  • Vydyborets S, Sergienko S. Complications and side effect when applying preparations of iron salts. Hematol. Transfusiol. Eastern Europe 2016;2(1):82–92
  • World Health Organization. Assessment of iron status in the human body by serum ferritin level: WHO recommendation [Internet]. Geneva: WHO; 2020. 82 p. Available from: https://www.who.int/publications/i/item/9789240000124
  • Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019;133(1):40–50. doi: 10.1182/blood-2018-06-856500
  • Ministry of Health Protection of Ukraine. Zalizodefizitna anemia. Adapted nastanov, based on evidence. Kyiv: MHU; 2015. 77 p.